Uncategorized

Eli Lilly given green light in US to treat sleep disorder with weight-loss drug – Financial Times

  1. Eli Lilly given green light in US to treat sleep disorder with weight-loss drug  Financial Times
  2. F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea  The New York Times
  3. FDA Approves First Medication for Obstructive Sleep Apnea  FDA.gov
  4. FDA approves weight-loss drug Zepbound for obstructive sleep apnea  CNN
  5. FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity  Investors | Eli Lilly and Company